FFCP PHASE1:Mm9::chr11:87430713..87430724,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=327992|HGNC=|MCL_coexpression_id=0|UniProt=Q5ND04|association_with_transcript=47bp_to_ENSMUST00000093956,NM_001045527,uc007kuc.1_5end|description=CAGE_peak_4_at_Hsf5_5end|id=chr11:87430713..87430724,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000473!5.42e-25!14;UBERON:0003135!2.45e-23!15;UBERON:0003101!6.92e-22!16;UBERON:0000079!6.92e-22!16;UBERON:0004176!1.32e-20!17;UBERON:0009196!1.32e-20!17;UBERON:0009117!1.32e-20!17;UBERON:0000991!1.82e-19!18;UBERON:0005564!1.82e-19!18;UBERON:0003133!1.29e-14!24;UBERON:0005156!1.71e-13!26;UBERON:0000990!1.71e-13!26;UBERON:0002323!1.79e-09!37;UBERON:0004458!1.79e-09!37;UBERON:0003886!3.20e-09!38;UBERON:0002553!5.53e-09!39|ontology_enrichment_uberon_v019_2=UBERON:0000473,4.05e-12,14;UBERON:0003135,2.29e-11,15;UBERON:0003101,1.05e-10,16;UBERON:0000079,1.05e-10,16;UBERON:0004176,4.01e-10,17;UBERON:0009196,4.01e-10,17;UBERON:0009117,4.01e-10,17;UBERON:0000991,1.33e-09,18;UBERON:0005564,1.33e-09,18;UBERON:0003133,2.18e-07,24;UBERON:0005156,7.12e-07,26;UBERON:0000990,7.12e-07,26|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.56885282344521,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.983110940922263,0,0,0,0,0,0,0,0,0,0,1.37020655662872,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.9138997881562,0,0,0.194451188344048,0.258319646955462,0,0,0,0.209718688851422,18.6019773036025,22.1783104818556,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p4@Hsf5}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=327992 | |||
|HGNC= | |||
|MCL_coexpression_id=0 | |||
|TSSclassifier=NA | |||
|UniProt=Q5ND04 | |||
|association_with_transcript=47bp_to_ENSMUST00000093956,NM_001045527,uc007kuc.1_5end | |||
|cluster_id=chr11:87430713..87430724,+ | |||
|description=CAGE_peak_4_at_Hsf5_5end | |||
|id=chr11:87430713..87430724,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000473!5.42e-25!14;UBERON:0003135!2.45e-23!15;UBERON:0003101!6.92e-22!16;UBERON:0000079!6.92e-22!16;UBERON:0004176!1.32e-20!17;UBERON:0009196!1.32e-20!17;UBERON:0009117!1.32e-20!17;UBERON:0000991!1.82e-19!18;UBERON:0005564!1.82e-19!18;UBERON:0003133!1.29e-14!24;UBERON:0005156!1.71e-13!26;UBERON:0000990!1.71e-13!26;UBERON:0002323!1.79e-09!37;UBERON:0004458!1.79e-09!37;UBERON:0003886!3.20e-09!38;UBERON:0002553!5.53e-09!39 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000473,4.05e-12,14;UBERON:0003135,2.29e-11,15;UBERON:0003101,1.05e-10,16;UBERON:0000079,1.05e-10,16;UBERON:0004176,4.01e-10,17;UBERON:0009196,4.01e-10,17;UBERON:0009117,4.01e-10,17;UBERON:0000991,1.33e-09,18;UBERON:0005564,1.33e-09,18;UBERON:0003133,2.18e-07,24;UBERON:0005156,7.12e-07,26;UBERON:0000990,7.12e-07,26 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.56885282344521,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.983110940922263,0,0,0,0,0,0,0,0,0,0,1.37020655662872,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.9138997881562,0,0,0.194451188344048,0.258319646955462,0,0,0,0.209718688851422,18.6019773036025,22.1783104818556,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p4@Hsf5 | |||
}} |
Latest revision as of 22:08, 25 September 2015
Short description: | p4@Hsf5 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_4_at_Hsf5_5end |
Coexpression cluster: | MCL_coexpression_mm9:0 |
Association with transcript: | 47bp_to_ENSMUST00000093956, NM_001045527, uc007kuc.1_5end |
EntrezGene: | Hsf5 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
testis | 4.05e-12 | 14 |
male reproductive organ | 2.29e-11 | 15 |
male organism | 1.05e-10 | 16 |
male reproductive system | 1.05e-10 | 16 |
external genitalia | 4.01e-10 | 17 |
indifferent external genitalia | 4.01e-10 | 17 |
indifferent gonad | 4.01e-10 | 17 |
gonad | 1.33e-09 | 18 |
gonad primordium | 1.33e-09 | 18 |
reproductive organ | 2.18e-07 | 24 |
reproductive structure | 7.12e-07 | 26 |
reproductive system | 7.12e-07 | 26 |